InfuSystem Holdings, Inc. — Third Quarter 2026 Earnings Summary

InfuSystem Holdings, Inc. reported net revenues of $37.6 million for the third quarter of 2026, representing a 3.0% increase from the prior year. The company achieved a net income of $3.2 million and an Adjusted EBITDA of $9.4 million, with the Adjusted EBITDA margin expanding to 24.9%. Growth was primarily driven by a 15% increase in Patient Services revenue, particularly in Oncology and Wound Care, which offset a 17% decline in Device Solutions revenue. Management reaffirmed its full-year 2026 guidance, projecting pro-forma revenue growth between 6% and 8% and Adjusted EBITDA margins in the low-to-mid 20% range.